Indication

Sarcoidosis

Sarcoidosis is a systemic inflammatory disorder of unknown etiology characterized by the formation of noncaseating granulomas in affected tissues. Read more about Sarcoidosis

334 drugs 161 manufacturers

Advertisement

Drugs that treat it

Common Sarcoidosis therapies.

Showing 100–108 of 334 drugs

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
QUALITEST/PAR P

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
QUALITEST/PAR P
Filter & compare in the drug finder →Opens the drug finder with Sarcoidosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Sarcoidosis.

Sarcoidosis is a systemic inflammatory disorder of unknown etiology characterized by the formation of noncaseating granulomas in affected tissues.

While it can involve virtually any organ system—including the skin, eyes, heart, liver, and central nervous system—it most commonly targets the respiratory tract, with intrathoracic lymphadenopathy and pulmonary parenchymal infiltration occurring in approximately 90% of cases.

Pathophysiologically, the disease is driven by an exaggerated cellular immune response, involving antigen-presenting cells and helper T lymphocytes, that triggers localized granulomatous inflammation and potential progressive fibrosis.

Clinical presentations vary widely from asymptomatic incidental findings on chest imaging to persistent cough, dyspnea, fatigue, or organ-specific dysfunction, frequently presenting in young to middle-aged adults.

Personalize your experience

Follow Sarcoidosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it